Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) induced Coronavirus Disease - 19 (COVID-19) cases have been increasing at an alarming rate (7.4 million positive cases as on June 11 2020), causing high mortality (4,17,956 deaths as on June 11 2020) and economic loss (a 3.2% shrink in gl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Beeraka, Narasimha M., Sadhu, Surya P., Madhunapantula, SubbaRao V., Rao Pragada, Rajeswara, Svistunov, Andrey A., Nikolenko, Vladimir N., Mikhaleva, Liudmila M., Aliev, Gjumrakch
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531039/
https://ncbi.nlm.nih.gov/pubmed/33072093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.552925
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars